Screener
NovoCure NVCR Other international markets — Net revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: NovoCure’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001645113-26-000062
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 | Year ended Year ended December 31, 2025 |
|---|---|---|---|---|---|
| International markets: | |||||
| Germany | 23,341 | 19,074 | 47,845 | 37,792 | 79,407 |
| France | 21,347 | 18,416 | 44,225 | 36,275 | 76,189 |
| Japan | 11,780 | 9,484 | 22,023 | 18,193 | 37,786 |
| Other international markets | 18,205 | 12,979 | 33,884 | 24,916 | 56,898 |
| International markets - Total | 74,673 | 59,953 | 147,977 | 117,176 | 250,280 |
| Greater China (1) | 5,956 | 4,591 | 10,751 | 9,208 | 19,441 |
| Total net revenues | $183,584 | $158,805 | $357,639 | $313,799 | $655,353 |
Item 1. Financial Statements
FAQ
- What is NovoCure's other international markets — net revenues?
- NovoCure (NVCR) reported other international markets — net revenues of $18.21M in Q2 2026.
- How has NovoCure's other international markets — net revenues changed year-over-year?
- NovoCure's other international markets — net revenues increased by 40.3% year-over-year, from $12.98M to $18.21M.
- What is the long-term trend for NovoCure's other international markets — net revenues?
- Over 4 years (2021 to 2025), NovoCure's other international markets — net revenues has grown at a 16.8% compound annual growth rate (CAGR), from $30.58M to $56.9M.
- What does other international markets — net revenues mean?
- This metric represents the total net revenue generated from the sale of medical devices and associated services within geographic regions outside of the company's primary domestic and major international markets. It reflects the company's ability to expand its commercial footprint and capture market share in emerging or secondary global territories. Monitoring this revenue stream helps investors assess the effectiveness of the company's international commercialization strategy and its success in navigating diverse regulatory and healthcare reimbursement landscapes.
Ask your AI about NovoCure's other international markets — net revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude